Aruba Health Monitor
SEE OTHER BRANDS

The best health and wellness news from Aruba

Aruba Health Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Health Monitor.

Press releases published on September 9, 2025

SoCalBio Investor Conference Kicks Off October 1st with Keynote by SetPoint Medical CEO

SoCalBio Investor Conference Kicks Off October 1st with Keynote by SetPoint Medical CEO

LOS ANGELES, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Southern California Biomedical Council (SoCalBio) today announced the agenda, speakers, and presenting companies for its 27th Annual Investor …

University of St. Augustine for Health Sciences to Host Third Annual Psychiatric Mental Health Summit

University of St. Augustine for Health Sciences to Host Third Annual Psychiatric Mental Health Summit

SAN MARCOS, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- The University of St. Augustine for Health Sciences (USAHS) will host its third Annual Psychiatric Mental Health Summit on September 27, 2025, at its St. Augustine, Florida campus. The summit will …

MULTIMEDIA UPDATE -- Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and Growth

MULTIMEDIA UPDATE -- Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and Growth

LONG BEACH, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announces the launch of the Hydrafacial Advisory Councils and Ambassador Network – a prestigious collective of …

New Medicaid Alliance to Tackle AI Safety and Standards Across States

New Medicaid Alliance to Tackle AI Safety and Standards Across States

MCLEAN, Va., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better health outcomes for its clients and the populations they serve, today announced the launch of the Safe …

Stephen Ubl Joins BrightInsight’s Board of Directors

Stephen Ubl Joins BrightInsight’s Board of Directors

SAN JOSE, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for digital health solutions, has announced that Stephen J. Ubl, President and CEO of Pharmaceutical Research and Manufacturers of America ( …

U.S. Oral Surgery Management Supports OMS Foundation

U.S. Oral Surgery Management Supports OMS Foundation

IRVING, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) is proud to announce its continued support of the OMS Foundation, a 501(c) (3) nonprofit that strives to improve the quality and safety of patient care by fueling …

Capricor Therapeutics Responds to FDA Posting of Complete Response Letter (CRL) for Deramiocel

Capricor Therapeutics Responds to FDA Posting of Complete Response Letter (CRL) for Deramiocel

SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today issued a statement regarding the U.S. Food and Drug …

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

SARASOTA, FL, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that the Japan Patent Office has granted …

Celldex to Present at Morgan Stanley 23rd Annual Global Healthcare Conference

Celldex to Present at Morgan Stanley 23rd Annual Global Healthcare Conference

HAMPTON, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that management will participate in a fireside chat today, September 9th, 2025, at the Morgan Stanley 23rd Annual Global Healthcare Conference at 3:20 pm …

Mark Mikhael Appointed to Make America Healthy Again PAC Board to Advance Positive Dialogue on Compounding and Patient-Centered Care

Mark Mikhael Appointed to Make America Healthy Again PAC Board to Advance Positive Dialogue on Compounding and Patient-Centered Care

ORLANDO, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Olympia and Wesley Pharmaceuticals, two of the nation’s leading compound pharmacies, announced today that their CEO, Mark Mikhael, PharmD, has been appointed to the board of Make America Healthy Again (MAHA …

Confluent Health Launches First-of-its-Kind Student Loan Repayment Program to Attract Next Generation of Physical, Occupational and Speech Therapy Professionals

Confluent Health Launches First-of-its-Kind Student Loan Repayment Program to Attract Next Generation of Physical, Occupational and Speech Therapy Professionals

LOUISVILLE, Ky., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Confluent Health, a national leader in musculoskeletal (MSK) care, today announced the launch of a groundbreaking student loan repayment initiative designed to attract top physical therapy (PT), …

All Heart Homecare Expands Services with Specialized Holocaust Program

All Heart Homecare Expands Services with Specialized Holocaust Program

BROOKLYN, N.Y., Sept. 09, 2025 (GLOBE NEWSWIRE) -- All Heart Homecare — Brooklyn’s premier home care agency and a trusted partner for families across New York City for over 13 years — is proud to expand its wide range of services by introducing the …

Tive Partners with AstraZeneca to Provide a Temperature Tracker for FluMist Home Delivery Program

Tive Partners with AstraZeneca to Provide a Temperature Tracker for FluMist Home Delivery Program

BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Tive, the global leader in real-time supply chain visibility solutions, has recently partnered with AstraZeneca to bring Tive Tag temperature visibility functionality to FluMist® Home, AstraZeneca’s at-home flu …

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress

Presentation to highlight findings from the first phase of the Company’s ongoing first-in-human proof-of-concept (PoC) clinical trial THE WOODLANDS, TX, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company …

Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Awarded grant supports dedicated pediatric continuous renal replacement therapy (CRRT) device in development for patients between 2.5 and 20 kg where therapeutic options are scarce Company working to advance Vivian™ towards an investigational device study …

Aviv Clinics Showcases New Study on Hyperbaric Oxygen Therapy’s Effectiveness in Improving Post-Concussion Symptoms from Childhood Traumatic Brain Injury

Aviv Clinics Showcases New Study on Hyperbaric Oxygen Therapy’s Effectiveness in Improving Post-Concussion Symptoms from Childhood Traumatic Brain Injury

ORLANDO, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- An estimated 2.3 million children in the U.S. are impacted by concussions annually. Yet, while the immediate effects of a concussion may subside, research shows that many individuals continue to experience …

Parexel Establishes New Global Headquarters in Raleigh’s North Hills Innovation District

Parexel Establishes New Global Headquarters in Raleigh’s North Hills Innovation District

RALEIGH, N.C., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced the opening of its new …

Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial

Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial

European expansion in September across Georgia, Italy, Lithuania, Poland, Romania, Spain, and US 13 subjects recruited (treated, enrolled, or screened) Forecasts total recruitment of 20 or more subjects by end of September On track to recruit to 45 …

Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy

Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy

Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development. New therapeutic options for people living with MSA, a rare …

Aphaia Pharma Initiates Second Phase 2 Trial of Oral Candidate in Obesity

Aphaia Pharma Initiates Second Phase 2 Trial of Oral Candidate in Obesity

Second Phase 2 trial builds on encouraging initial results from a prior Phase 2 study Aphaia’s formulation activates gastrointestinal nutrient-sensing signaling pathways to modify the course of obesity and associated metabolic diseases ZUG, Switzerland, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions